Temukan Dokter Spesialis untuk Anda

Dr. Aiden Heng Fook Yew

Kanker · Kuching

Dr Aiden Heng Fook Yew is a Clinical Oncologist specialising in cancer diagnosis, treatment planning, and systemic therapy.

Dr. Karmen Wong 黄洁儿医生

Kanker · Singapore

Medical oncologist specializing in breast, gastrointestinal, and gynecological cancers with extensive experience in multidisciplinary cancer care

Farhat Aziz Khan

Kanker · Penang

Dr Daniel Wong Wai YanMRCP (UK)

Kanker · Melaka City

Dr Daniel Wong Wai Yan is a Clinical Oncologist specialising in cancer diagnosis, radiotherapy, and systemic cancer treatments.

Dr Ng Boon Huat

Kanker · Petaling Jaya

Consultant Clinical Oncologist at Beacon Hospital specialising in adult malignancies and advanced radiotherapy, with expertise in systemic cancer therapies.

Dr. Santhi A/P Nadarajan

Kanker · Kuala Lumpur

Clinical oncologist specialising in cancer diagnosis, radiotherapy, and multidisciplinary cancer care.

Dr. Shang Yeap Heng Oon 叶昇运医生

Kanker · Singapore

Dr. Shang Yeap Heng Oon is a Medical Oncologist specialising in breast, gastrointestinal, lung, urogenital cancers, and melanoma treatment.

Assoc. Prof. Dr. Aminudin Rahman Mohd MydinFRCR (UK)

20+ tahun pengalaman · Kanker · Petaling Jaya

Consultant Clinical and Radiation Oncologist with expertise in advanced radiotherapy, chemotherapy, immunotherapy, and cancer care.

Tan Ai Lian

Kanker · Penang

Zee Ying Kiat

Kanker · Singapore

Dr Zee Ying Kiat adalah ahli onkologi medis di Mount Elizabeth Hospital, Singapura. Beliau sangat berpengalaman dalam onkologi medis umum dan memiliki minat khusus pada kanker gastro-esofagus, hepatobilier, pankreas, dan kolorektal. Beliau pernah menjabat sebagai konsultan ahli onkologi medis di National University Cancer Institute, Singapore (NCIS). Dr Zee lulus dari University College London, UK. Beliau bekerja di Royal Marsden Hospital di London sebelum menyelesaikan pelatihan spesialis onkologi medis di National University Hospital. Selanjutnya beliau menjalani pelatihan fellowship di The Christie Hospital dan Paterson Institute for Cancer Research di Manchester, UK, dengan fokus pada pengembangan obat anti-kanker. Beliau adalah anggota American Society of Clinical Oncology dan anggota pendiri Hepatopancreatobiliary Association of Singapore. Beliau merupakan anggota dewan Mount Elizabeth Hospital's medical advisory board, National Healthcare Group's domain specific review board dan chapter of medical oncologists, College of Physicians, Singapore. Komitmennya terhadap penelitian telah diakui melalui berbagai hibah termasuk National Medical Research Council's clinician investigator support grant dan NCIS investigator protected time grant. Di NCIS, beliau melakukan penelitian klinis dan translasional sebagai peneliti utama atau peneliti bersama dalam uji klinis lokal dan internasional yang melibatkan terapi bertarget novel untuk kanker kolorektal, lambung, hati dan pankreas. Beliau telah mempublikasikan karyanya sebagai penulis pertama di berbagai jurnal termasuk British Journal of Cancer, Journal of Clinical Oncology, Lancet Oncology dan Nature Reviews. Dr Zee adalah penerima Excellent Service Award dari SPRING Singapore.

Tanujaa D/O RajasekaranMRCP (UK)

Kanker · Singapore

Dr Tanujaa Rajasekaran adalah seorang onkolog medis di Mount Elizabeth Hospital, Singapura. Beliau berpengalaman dalam onkologi medis umum, dengan minat subspesialisasi dalam penanganan kanker paru-paru, genitourinari, kepala dan leher, serta onkologi geriatri. Sebelum bergabung dengan praktik swasta, Dr Tanujaa adalah konsultan di National Cancer Centre Singapore (NCCS) dan direktur medis di unit onkologi Changi General Hospital. Beliau lulus dari National University of Singapore (NUS). Setelah itu, beliau memperoleh gelar master dari NUS dan keanggotaan Royal College of Physicians, UK. Selanjutnya, beliau menyelesaikan pelatihan spesialis dalam onkologi medis di NCCS. Beliau telah berpraktik dalam bidang kedokteran selama lebih dari 15 tahun. Di luar pekerjaan klinisnya, Dr Tanujaa aktif terlibat dalam pendidikan medis. Beliau adalah anggota fakultas inti dari program residensi senior onkologi medis dan dosen klinis di Yong Loo Lin School of Medicine, NUS. Beliau juga merupakan asisten profesor di Duke-NUS Medical School. Beliau telah menerbitkan artikel di beberapa jurnal internasional terkemuka. Beliau adalah anggota American Society of Clinical Oncology, European Society of Medical Oncology dan International Society of Geriatric Oncology (SIOG). Beliau juga merupakan perwakilan nasional Singapura untuk SIOG. Dr Tanujaa telah menerima berbagai penghargaan termasuk SingHealth Quality Service awards.

Chin Tan Min

Kanker · Singapore

Dr Chin Tan Min is a medical oncologist at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. Her areas of expertise lie in lung cancers and general oncology. She was awarded the Health Manpower Development Programme (HMDP) fellowship to pursue further subspecialisation training in thoracic oncology, with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre in the US. Prior to private practice, she was a senior consultant at the National University Cancer Institute at NUH, and a visiting consultant at Ng Teng Fong Hospital. Dr Chin contributes her expertise in thoracic oncology in various Ministry of Health committees, formulating guidelines on screening and treatment for lung cancers. She is also an advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was also core faculty for the oncology senior residency programme at National University Health System. She is the principal associate at the Cancer Science Institute of Singapore, where she continues her current research. She is a member of American Society of Clinical Oncology, American Association for Cancer Research, and the International Association of Lung Cancer. With a keen and active interest in translational and clinical research to better patient care, she has conducted several international industry-sponsored and investigator-initiated clinical trials as principal and co-investigator. Dr Chin’s work has been published in peer-reviewed, high-impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. She contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood. Her commitment to patient care has been recognised by SPRING’s Excellent Service Award.